Compare Bellus Health vs Phenomix
Customers evaluate the quality of Bellus Health's products using the following success metrics.
Overview
Bellus Health is 31 yrs old and is based in Canada.
BELLUS Health (NASDAQ: BLU) operates as a global health company focused on the development and commercialization of products to provide health solutions. It specializes in the development of therapeutic solutions for treating patients with chronic cough and hypersensitization-related disorders. Bellus Health was formerly known as Neurochem. The company was founded in 1993 and is based in Laval, Canada. In June 2023, Bellus Health was acquired by GSK.
Phenomix is 23 yrs old and is based in United States.
Phenomix a biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule product candidates directed toward clinically validated targets in significant therapeutic markets.
Demo Video
Leadership
Roberto Bellini (Chief Executive Officer, President)
Keats Nelms (Founder)
Investors
GSK, OrbiMed Advisors
Presidio Partners, Sofinnova Ventures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Bellus Health has not claimed their profile.
Work for Bellus Health? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Bellus Health?
Claim your profile now.
Information not available because Phenomix has not claimed their profile.
Work for Phenomix? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Phenomix?
Claim your profile now.